Co-Authors
This is a "connection" page, showing publications co-authored by MARTIN MATZUK and Zian Liao.
Connection Strength
3.801
-
The long road of drug development for endometriosis - Pains, gains, and hopes. J Control Release. 2024 Dec; 376:429-440.
Score: 0.981
-
Affinity-tagged SMAD1 and SMAD5 mouse lines reveal transcriptional reprogramming mechanisms during early pregnancy. Elife. 2024 Mar 27; 12.
Score: 0.943
-
Affinity-tagged SMAD1 and SMAD5 mouse lines reveal transcriptional reprogramming mechanisms during early pregnancy. bioRxiv. 2024 Feb 07.
Score: 0.934
-
Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology. Proc Natl Acad Sci U S A. 2024 Nov 19; 121(47):e2413108121.
Score: 0.246
-
Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology. Proc Natl Acad Sci U S A. 2024 May 07; 121(19):e2322934121.
Score: 0.237
-
Inhibition of CSF1R and KIT With Pexidartinib Reduces Inflammatory Signaling and Cell Viability in Endometriosis. Endocrinology. 2024 Feb 20; 165(4).
Score: 0.234
-
Oocyte-specific Wee1-like protein kinase 2 is dispensable for fertility in mice. PLoS One. 2023; 18(8):e0289083.
Score: 0.225